CNH Partners

CNH Partners is an investment management firm that specializes in arbitrage-based strategies, particularly merger arbitrage and convertible arbitrage. Founded in 2001 and operating as a subsidiary of AQR Capital Management since 2004, the firm is a significant institutional investor in the life sciences and biotechnology sectors. While not a drug developer itself, CNH Partners is frequently involved in the financial side of the healthcare industry, participating in the arbitrage of major pharmaceutical acquisitions and maintaining positions in numerous publicly traded biotech companies. The firm is headquartered in Greenwich, Connecticut, and manages assets for a global client base of institutional and individual investors.